Related Experiment Video
Updated: Aug 30, 2026

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
Hemopoietic stem cell transplantation in refractory rheumatoid arthritis is not a contraindication for reconstructive
I Espigado1, A García, J M Rodríguez
1Servicio de Hematología y Hemoterapia, Hospitales Universitarios Virgen del Rocío, Servicio Andaluz de Salud, Avda. Manuel Siurot s/n, Sevilla 41013, Spain.
Abstract:
Hemopoietic stem cell transplantation (HCST) is an experimental therapy that may produce prolonged remissions in patients with rheumatoid arthritis (RA) resistant to other treatments. Prosthetic articular replacement is often required in severe long-lasting disease. There is a well-founded concern regarding the feasibility and safety of reconstructive surgery after HSCT and as yet no published data on the subject. We report a patient with RA of 9 years' duration resistant to conventional treatments plus femoral head necrosis, who underwent prosthetic hip replacement with no post-surgical complications one year after HSCT, with a sustained response.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Rheumatic Heart Disease I: Introduction
